This inventor holds 2 USPTO granted patents. Top assignees: Nisshin Chemicals Co., Ltd., Nisshin Flour Milling Co., Ltd.. Active years: 1986-1992.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1986-1992
Title: Takeo Iijima: Innovator in Pharmaceutical Preparations
Introduction
Takeo Iijima is a notable inventor based in Koushoku, Japan. He has made significant contributions to the field of pharmaceutical preparations, holding 2 patents that showcase his innovative approach to drug formulation.
Latest Patents
Iijima's latest patents include groundbreaking pharmaceutical preparations containing non-steroidal anti-inflammatory agents. These preparations are designed for oral administration and consist of an acidic non-steroidal anti-inflammatory agent with a mean particle size of about 100 µm or less, combined with a protein hydrolyzate or a polypeptide with a mean molecular weight of 4000-12000. The formulations are available in various forms, including tablets, granules, capsules, and dry syrups, achieving high bioavailability of the anti-inflammatory agent, such as ibuprofen. Another notable patent is for a soft capsule containing γ-oryzanol, either alone or in combination with riboflavin butyrate. This composition enhances shelf life without ingredient precipitation.
Career Highlights
Throughout his career, Iijima has worked with prominent companies, including Nisshin Flour Milling Co., Ltd. and Nisshin Chemicals Co., Ltd. His experience in these organizations has contributed to his expertise in pharmaceutical innovations.
Collaborations
Iijima has collaborated with esteemed colleagues, including Masaki Otagiri and Masao Ueno. Their joint efforts have further advanced the field of pharmaceutical preparations.
Conclusion
Takeo Iijima's contributions to pharmaceutical innovations reflect his dedication to improving drug formulations. His patents demonstrate a commitment to enhancing the efficacy and stability of pharmaceutical products.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile